Liuxiang Chu
Key Laboratory Of Molecular Pharmacology And Drug Evaluation
Yantai, China
Yantai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The Tumor-Derived Exosomes Enhanced Bevacizumab across the Blood-Brain Barrier for Antiangiogenesis Therapy against Glioblastoma.
Journal: Molecular pharmaceutics
Published: February 03, 2025
Targeted thermosensitive liposomes loaded with gold nanoparticles and temozolomide hexadecanoate for the synergistic photothermal-chemotherapy treatment of glioblastoma.
Journal: Journal of pharmaceutical sciences
Published: October 11, 2024
Release mechanism and pharmacodynamics of entecavir micro spheres.
Journal: Pakistan journal of pharmaceutical sciences
Published: May 14, 2024
Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy.
Journal: International journal of pharmaceutics
Published: January 23, 2024
Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-β1 blockade.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 18, 2023
Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy.
Journal: Drug delivery
Published: February 25, 2023
Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration.
Journal: Frontiers in pharmacology
Published: June 13, 2022
Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
Journal: Molecular pharmaceutics
Published: March 09, 2022
Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study.
Journal: Journal of pharmaceutical sciences
Published: April 14, 2021
Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation.
Journal: Pharmaceutical development and technology
Published: August 02, 2019
Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease.
Journal: Drug delivery
Published: July 11, 2019
Last Updated: 09/26/2026